Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) EV/EBITDA
As of 5 November 2026, Chemed Corporation (CHE) trades at a EV/EBITDA of 16.3×. Over the past ten years it has ranged from 9.1× (January 2015) to 33.2× (May 2018); the current reading is higher than 33% of that period. That is above the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 15.3× | (16.35%) |
| FY2024 | 18.3× | (14.63%) |
| FY2023 | 21.5× | 14.07% |
| FY2022 | 18.8× | (10.75%) |
| FY2021 | 21.1× | 11.27% |
| FY2020 | 19.0× | (19.62%) |
| FY2019 | 23.6× | 44.01% |
| FY2018 | 16.4× | (39.23%) |
| FY2017 | 27.0× | 111.62% |
| FY2016 | 12.7× | 7.96% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 15.5× | 3.11% |
| Jun 2026 | 15.0× | 12.73% |
| Mar 2026 | 13.3× | (13.26%) |
| Dec 2025 | 15.3× | (0.53%) |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.1× |
| UHS Universal Health Services, Inc. compare | 6.4× |
| DVA DaVita Inc. compare | 8.0× |
| OPCH Option Care Health, Inc. compare | 13.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 14.0× |
| PACS PACS Group, Inc. compare | 16.2× |
| CHE Chemed Corporation | 16.3× |
| ENSG The Ensign Group, Inc. compare | 16.4× |
| LFST LifeStance Health Group, Inc. compare | 32.0× |
| Medical Care Facilities industry median | 11.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement